Andrew M Korda, MSHC

Andrew brings over 10 years of experience in the health care and pharmaceutical industry, having developed and executed effective communication strategy—leveraging integrated plans, campaigns, and materials for diverse audiences and stakeholders including patients, providers, policymakers, and the public. Andrew has led global communications for priority assets, including the launch of ALTIVIIIO® and has represented a robust portfolio of established and novel first/best-in-class therapies.

Andrew’s passion for health communication stems from a curiosity for science and his personal experience as a coach and former athlete. Andrew holds a Master of Science Degree in Health Communications from Boston University and believes that communication is a powerful tool to promote health literacy, advocacy, and behavior change; and to foster trust, collaboration, and innovation in the health sector.